Pregnancy and anti-obesity drugs: risks still poorly assessed

GLP-1 agonists, used against obesity, raise questions about their safety during pregnancy.

Published 2h2 sources✓ ConfirmedNotableupdated 1h

≈ 18sSpeed

The fact

No clinical study has yet established a direct link, but cases of malformations have been reported.

Health authorities recommend avoiding these treatments if pregnancy is planned.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on September 24, 2026